An hypochlorous acid-responsive NIR-IIb nanosensor for In Vivo monitoring of inflammatory bowel disease progression
Acta Biomaterialia · 2026-03 · 213 · 567-578
DOI: 10.1016/j.actbio.2026.01.047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biomaterialia, 2026-03. Verfasst von Qian Jia und 10 weiteren Autor:innen. Beteiligte Einrichtung: Lab of Molecular Imaging and Translational Medicine (MITM), Engineering Research Center of Molecular and Neuro Imaging, Ministry of Education, School…. Hauptthemen laut MEDLINE: Hypochlorous Acid, Inflammatory Bowel Diseases, Nanoparticles, Disease Progression. Die Arbeit nennt 42 Literaturangaben. Gefördert von: Society of Hong Kong Scholars, Natural Science Basic Research Program of Shaanxi Province, Key Technologies Research and Development Program.
Abstract (Originalsprache)
Accurate assessment of inflammatory bowel disease (IBD) severity is crucial for optimizing treatment decisions and improving prognosis. However, conventional assessment methods are time-consuming and primarily detect anatomical changes at moderate or late stages, limiting timely intervention. Here, we report an HClO‑responsive NIR‑IIb ratiometric nanosensor (CSSS@PMH‑mPEG2000) that combines down‑conversion core-shell nanoparticles with strong NIR‑IIb emission under 808/980 nm excitation and an HClO‑responsive IR780MA dye. By means of dye sensitizing mechanism, the sensor enables dynamic ratiometric quantification of HClO and supports real-time assessment of IBD progression and severity. Comprehensive in vitro and in vivo studies validate CSSS@PMH‑mPEG2000 as a highly sensitive and reliable platform for real-time, quantitative HClO monitoring of IBD in a mouse model. Moreover, ratiometric NIR‑IIb fluorescence imaging effectively captures changes in disease severity, highlighting its potential for assessing treatment efficacy. Together, these findings underscore the translational value of CSSS@PMH‑mPEG2000 for advancing IBD diagnosis and management, while also demonstrating its broader applicability to in situ HClO detection across a range of inflammatory diseases. STATEMENT OF SIGNIFICANCE: Accurate IBD severity assessment is vital for optimizing treatment and prognosis, but conventional methods are time‑consuming and detect mainly mid‑to‑late anatomical changes, delaying intervention. We present an HClO‑responsive NIR‑IIb ratiometric nanosensor (CSSS@PMH‑mPEG2000) combining down‑conversion core-shell nanoparticles with an HClO‑responsive IR780MA dye. Using dye sensitizing mechanism, it enables dynamic ratiometric HClO quantification and real‑time evaluation of IBD progression and severity. In vitro and in vivo studies in a mouse IBD model demonstrate high sensitivity and reliability for real‑time, quantitative HClO monitoring. Ratiometric NIR‑IIb imaging captures disease‑severity changes and supports treatment‑efficacy assessment, underscoring the platform's translational value for IBD management and broader in situ HClO detection in inflammatory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lab of Molecular Imaging and Translational Medicine (MITM), Engineering Research Center of Molecular and Neuro Imaging, Ministry of Education, School of Life Science and Technology, Xidian University, Xi'an, Shaanxi, 71…
- CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Chinese Academy of Sciences, Beijing, 100190, PR China.
- Center of Super-Diamond and Advanced Films (COSDAF) and Department of Chemistry, City University of Hong Kong, Hong Kong SAR, 000000, PR China. Electronic address: apcslee@cityu.edu.hk.
Förderung
- Society of Hong Kong Scholars
- Natural Science Basic Research Program of Shaanxi Province
- Key Technologies Research and Development Program
- Basic and Applied Basic Research Foundation of Guangdong Province
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Department of Science and Technology of Guangdong Province
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Jia, Q., Fu, Y., Bai, M., Xu, X., Zhong, Y., Yan, H., Feng, Y., Jia, Y., Zhang, R., Wang, Z., & Lee, C. S. (2026). An hypochlorous acid-responsive NIR-IIb nanosensor for In Vivo monitoring of inflammatory bowel disease progression. Acta Biomaterialia, 213, 567-578. https://doi.org/10.1016/j.actbio.2026.01.047
Vancouver
Jia Q, Fu Y, Bai M, Xu X, Zhong Y, Yan H, et al. An hypochlorous acid-responsive NIR-IIb nanosensor for In Vivo monitoring of inflammatory bowel disease progression. Acta Biomaterialia. 2026;213:567-578. doi:10.1016/j.actbio.2026.01.047
BibTeX
@article{Jia2026,
author = {Jia, Qian and Fu, Yuqing and Bai, Mingli and Xu, Xiaojie and Zhong, Yeteng and Yan, Haohao and Feng, Yanbin and Jia, Yuanyuan and Zhang, Ruili and Wang, Zhongliang and Lee, Chun-Sing},
title = {An hypochlorous acid-responsive NIR-IIb nanosensor for In Vivo monitoring of inflammatory bowel disease progression},
journal = {Acta Biomaterialia},
year = {2026},
volume = {213},
pages = {567--578},
doi = {10.1016/j.actbio.2026.01.047}
}
EUVIMED